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Abstract 
Background: Helicobacter cinaedi causes bacteremia and cellulitis, mainly in immunocompromised patients. We 
report a rare case of H. cinaedi bacteremia with cellulitis in a living-donor kidney transplant recipient identified by 
matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS).
Case summary: A 54-year-old Asian man with IgA nephropathy underwent living-donor kidney transplantation 
14 years previously. He was admitted to our hospital for evaluation of fever and multifocal cellulitis. H. cinaedi was 
isolated and identified from the patient’s blood using matrix-assisted laser desorption ionization time-of-flight mass 
spectrometry and gyrase subunit B-targeted polymerase chain reaction assays. Matrix-assisted laser desorption ioniza-
tion time-of-flight mass spectrometry has proven over the years to be a rapid and accurate universal method for the 
identification of microorganisms.
Conclusions: The combined use of these detection methods enabled the appropriate administration of 6 weeks of 
antibiotic therapy. The patient recovered completely, with no recurrence.
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Background
Helicobacter cinaedi is a gram-negative enterohepatic 
spiral bacillus found in the digestive tracts of humans 
and animals (e.g., dogs, cats, and hamsters). This organ-
ism was first isolated from rectal cultures from homo-
sexual men in 1984 [1]. Since that time, H. cinaedi 
infections have been detected from blood and stool 
samples obtained mainly from immunocompromised 
patients [2]. The first case of H. cinaedi infection in 
Japan in an immunosuppressed patient was reported in 
2003 [3]. However, recent reports have demonstrated 
that this organism can cause nosocomial infections in 
immunocompetent patients after orthopedic surgery 
[4]. The reported detection rate of H. cinaedi among 
positive blood cultures (i.e., blood samples with any 
positive culture result) in Tokyo, Japan is 0.22% [5]. The 
clinical manifestations of H. cinaedi infection include 
fever, enterocolitis, diarrhea, cellulitis, arthritis, menin-
gitis, and recurrent bacteremia. Isolation of H. cinaedi 
requires a long incubation period in automated blood 
culture, and this pathogen is sometimes resistant to mac-
rolides and quinolones [6]. For these reasons, H. cinaedi 
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infections tend to be overlooked, are likely to recur, and 
often require long-term antibiotic therapy. In addition, 
data on H. cinaedi infection in kidney transplant recipi-
ents are very limited; only five cases have been reported 
to date [3, 7]. Several genomic methods, such as 16S 
rRNA sequencing and polymerase chain reaction (PCR), 
can be used to identify H. cinaedi. Matrix-assisted laser 
desorption ionization time-of-flight mass spectrometry 
(MALDI-TOF MS) is a new technology for routine iden-
tification of bacteria in clinical microbiology laboratories. 
Here, we report a case of H. cinaedi bacteremia with cel-
lulitis in a living-donor kidney transplant recipient iden-
tified by MALDI-TOF MS, with a review of the related 
literature.
Case presentation
A 54-year-old Asian man with IgA nephropathy under-
went living-donor kidney transplantation 14  years pre-
viously. His medical condition had been almost stable 
for 14  years. He developed multifocal salmon-pink skin 
discoloration, and swelling and spontaneous pain in the 
left knee and leg. The symptoms had gradually expanded 
across the right forearm and outside of the right thigh. 
He was admitted to our hospital for the evaluation 
of fever (39  °C) and multifocal cellulitis (Fig.  1). Two 
months before admission, he had developed chronic 
diarrhea. His serum creatinine level was stabilized at 
1.7  mg/dL with maintenance immunosuppressive ther-
apy comprising tacrolimus (3  mg/day), mycophenolate 
mofetil (1500 mg/day), and prednisone (4 mg every other 
day). The tacrolimus trough concentration was 6.3  ng/
mL. The patient had been a dog breeder for 12  years. 
On admission, his white blood cell count was 12,400/
μL and his C-reactive protein level was 3.9  mg/dL. The 
patient was initially treated with ampicillin/sulbactam 
(9  g/day intravenously). Two days after the initiation of 
this therapy, he was afebrile. Four days later, an auto-
mated blood culture (Bactec FX®; Becton–Dickinson 
and Company, Sparks, MD, USA) showed positivity for 
gram-negative spiral bacilli. A colony obtained from the 
patient’s blood culture was analyzed by MALDI-TOF MS 
(Biotyper ver. 3.0®; Bruker Corporation, Germany). The 
identification score was 2.064 (>2.0), indicating accurate 
identification of H. cinaedi (Fig. 2). Additional evaluation 
of the patient’s blood specifically for H. cinaedi by means 
of gyrase subunit B (gyrB)-targeted PCR assays (using 
the forward primer AGGGATTCCACAAAGTGAGC 
and the reverse primer TCTTGTCCTGTGCGTTCATC 
to amplify the region of the gyrB gene) yielded positive 
results. We performed gyrB-targeted PCR using a single 
colony isolated from a blood culture. We used distilled 
water (DNA- and DNase-free water) as a negative control 
to prevent contamination of gyrB-targeted PCR (Fig. 3). 
In addition, we performed 16S rRNA gene sequencing of 
this strain, and the results were > 99% consistent with the 
existing sequence (Fig.  4). Given these results, we diag-
nosed the patient with H. cinaedi bacteremia with cellu-
litis. We examined the genomic heat shock protein (HSP) 
60 sequence of the blood culture isolate, which resulted 
in identification of cluster B H. cinaedi. A blood culture 
obtained at 11 days was positive for H. cinaedi, but a cul-
ture obtained at 15 days was negative. The patient’s cellu-
litis gradually resolved. The patient continued antibiotic 
treatment for a total of 6  weeks (ampicillin-sulbactam 
in a drip for 2 weeks and oral levofloxacin for 4 weeks), 
and he had no recurrence 6  months after this therapy. 
His stool culture was negative, although it was taken after 
treatment. We did not apply enteric bacteria elimination 
in this case.
Discussion
Helicobacter cinaedi infection in kidney transplant recip-
ients remains poorly understood. Only six cases, includ-
ing our case, have been reported to date. All six cases 
had a positive blood culture, and four of these patients 
had cellulitis [3, 7]. The correlation between H. cinaedi 
infection and kidney transplantation may be due to 
the use of immunosuppressive agents. The tacrolimus 
trough concentration in our patient was slightly higher 
than expected. The infectious route of this pathogen has 
not been clarified. Imafuku et al. [7] recently speculated 
that translocation from the intestine to the blood vessels 
induced secondary bacteremia with several of the symp-
toms described in these cases, as H. cinaedi bacteremia 
developed after colonic perforation in two of four cases.
Fig. 1 Left, cellulitis in the left lower leg and knee. Local swelling with 
salmon-pink skin discoloration and local heat with spontaneous pain 
was evident. Right, left leg after 6 weeks of antibiotic therapy
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In general, the distinct clinical features of H. cinaedi 
bacteremia include fever, enterocolitis, diarrhea, cel-
lulitis, arthritis, meningitis, and recurrent bacteremia. 
Cellulitis in this condition has the distinct characteris-
tic features of multifocal salmon-pink skin discoloration 
with no wound infection [6]. In our case, such skin dis-
coloration with swelling and spontaneous pain was evi-
dent. H. cinaedi infection should thus be included in the 
differential diagnosis of multifocal cellulitis accompanied 
by fever in kidney transplant recipients.
The detection of H. cinaedi is difficult for two reasons: 
(1) 4–10 (median, 5) days are required for the detec-
tion of these slow-growing pathogens in blood culture, 
and (2) they grow in film-like shapes and are likely to go 
unnoticed [6]. The reported lengths of time required for 
detection of H. cinaedi in kidney transplant recipients are 
5, 7, 4, 3, and 4 days; in our case, 4 days were required. 
Therefore, Araoka et al. [8] speculated that the observa-
tion period should be extended to at least 7  days when 
a clinician suspects infection with this pathogen. In 
addition, Kawamura et  al. [6] pointed out differences in 
detection sensitivity among blood culture systems; the 
VersaTREK system® (Kohjin Bio, Saitama, Japan) is supe-
rior to the Bactec system, which we used. The former sys-
tem can detect the pathogen within 3 days, whereas the 
latter system requires 4–10 days.
We performed additional assays to identify the infect-
ing strain in our case because the commercially avail-
able detection kit has limitations: few strains are included 
in the kit, and the identification rate of the kit requires 
improvement. The accuracy of 16S rRNA gene sequence 
analysis is also limited because of the high degree of 
Fig. 2 Intact-cell mass spectrometry profiling using matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Upper panel, 
intact-cell mass spectrometry profiles from our case; lower panel, the reference case. Table at bottom shows the identification score using the 
integrated pattern-matching algorithm of the MALDI Biotyper 3.0 software® (Bruker Corp., Germany). The patient’s identification score was 2.064. A 
score of ≥2.0 is useful for identification to the species level
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similarity among closely related Helicobacter species [9]. 
GyrB-targeted PCR is more specific for H. cinaedi [8]. 
MALDI-TOF MS has proven over the years to be a sim-
ple, rapid, and accurate universal method for the identifi-
cation of microorganisms, including H. cinaedi strains [9].
Minimal preparation is required for MALDI-TOF MS 
[10]. Samples are overlaid with a suitable matrix (alpha-
cyano-4-hydroxycinnamic acid in 50% acetonitrile and 
2.5% trifluoroacetic acid) and left for a few minutes to dry 
before being subjected to the mass spectrometry. After 
adding the organic matrix to the biomolecules, co-crys-
tallization proceeds rapidly in a spatial array on the target 
plate. The size and intensities of the peaks of the detected 
molecules depend on the matrix selected. Then the mixed 
sample receives a fixed, pulsed laser beam. The part of the 
matrix gets heated and the mixed sample become excited 
and ionized states. Ionized molecules are accelerated 
electronically and converted from TOF measurements to 
mass/charge values. The result is shown as a spectrum. 
Each spectrum corresponds to a molecular fragment of 
the cell during laser desorption. The same bacterium can 
yield different mass spectra. Protein mass patterns can be 
used for identification of bacteria at the genus and species 
levels [11]. Brucker Corporation has an algorithm for phy-
logenetic analysis, which has not been published. Many 
studies have shown that MALDI-TOF MS decreases both 
the time to bacterial identification and the time to effec-
tive antibiotic therapy [12, 13]. Regarding the rapidity 
of identification of bacteria, Seng et  al. [14] estimated a 
mean time to identification by MALDI-TOF MS of 6 min, 
whereas conventional techniques require 3–48 h. The cost 
of bacterial identification by MALDI-TOF MS was esti-
mated by Seng et al. [14] to be 17–32% of that of conven-
tional identification methods.
In our case, MALDI-TOF MS showed positivity for H. 
cinaedi earlier than gyrB-targeted PCR, enabling us to 
determine rapidly that a 6-week period of antibiotic ther-
apy was appropriate.
Although no report has described the isolation of the 
same H. cinaedi strain from a human patient and his/
her pet, H. cinaedi infection is thought to be zoonotic 
[6]. In our case, subsequent gyrB-targeted PCR analysis 
of a stool sample from the patient’s pet yielded negative 
results. Taniguchi et  al. [9] speculated that H. cinaedi 
comprises two different lineages defined by HSP60 
sequences: (1) cluster A from animals and (2) cluster B 
from humans. We examined the HSP60 sequence of the 
patient’s blood culture and identified cluster B H. cinaedi. 
Taken together, these findings suggest that our patient 
was not infected from his dog.
The reason that a blood culture obtained at 11  days 
was positive and a culture obtained at 15 days was nega-
tive in our case is unclear. We speculate that complete 
eradication of H. cinaedi required a prolonged period of 
antibiotic treatment, possibly because of infection of an 
atherosclerotic plaque. Khan et  al. [15] reported detec-
tion of H. cinaedi antigen in atherosclerotic plaques in 
postmortem human specimens.
Fig. 3 Detection of Helicobacter cinaedi in blood using gyrase subu-
nit B-targeted polymerase chain reaction. M molecular size marker, 
Nc negative control: distilled water (DNA- and DNase-free water). 
Polymerase chain reaction was performed using the forward primer 
AGGGATTCCACAAAGTGAGC and the reverse primer TCTTGTCCTGT-
GCGTTCATC. This resulted in a product of 195 base pair
Fig. 4 Partial sequence of the Helicobacter cinaedi 16S rRNA gene
Page 5 of 5Katsuma et al. BMC Res Notes  (2017) 10:87 
No guideline for the antibiotic treatment of H. cinaedi 
infection has been established. Because many reports 
indicate that H. cinaedi infection is likely to recur, a 2- to 
6-week duration of antibiotic therapy has been recom-
mended. Although one report described positive results 
of selective decontamination of the digestive tract [7], 
even in cases of initial H. cinaedi infection, the effective-
ness of this eradication therapy remains undetermined.
Conclusions
We have described a rare case of H. cinaedi bacteremia 
with cellulitis in a living-donor kidney transplant recipi-
ent, which was identified by MALDI-TOF MS. In this 
paper, we wish to emphasize the importance of rapid and 
accurate identification of the pathogenic bacterium. A 
positive blood culture of gram-negative spiral bacilli from 
immunocompromised patients is suggestive of infection 
by H. cinaedi, and in such cases the bacterium should be 
identified rapidly. H. cinaedi infection should be included 
in the differential diagnosis of multifocal cellulitis with 
fever, especially in immunocompromised patients. 
MALDI-TOF MS is a simple, rapid, and accurate method 
of H. cinaedi detection.
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